Partner with a Leading Human Biospecimen Provider
Experience swift and ethical biospecimen acquisition tailored to your research needs.
Human Biospecimen Collection with MT Group: Your 2025 Guide to Quality Samples
Unlock translational research with MT Group’s expertise in human biospecimen collection, delivering ethically sourced samples and comprehensive clinical metadata.
Introduction
Human biospecimen collection is the backbone of translational research, enabling groundbreaking discoveries in oncology, autoimmune diseases, and infectious diseases. High-quality, ethically sourced samples paired with comprehensive clinical metadata empower researchers to develop novel therapeutics and diagnostics. MT Group, a Los Angeles-based Contract Research Organization (CRO) established in 2003, leads the industry in providing tailored human biospecimen collection services. This 2025 guide explores how MT Group’s expertise drives research success, offering insights into their processes and capabilities.
Whether you’re studying cancer biomarkers or autoimmune mechanisms, MT Group ensures reliable access to pristine samples. Let’s explore why human biospecimen collection is critical and how MT Group sets the standard.
The Importance of Human Biospecimen Collection
Human biospecimen collection involves acquiring biological materials—such as tissue, blood, and biofluids—for research, ensuring they are ethically sourced and accompanied by detailed clinical data. These samples are vital for advancing biomedical research, as highlighted by the National Cancer Institute, which notes their role in precision medicine and biomarker discovery.
- Precision Medicine: Tumor tissues and blood samples support projects like The Cancer Genome Atlas, driving personalized therapies.
- Biomarker Discovery: Liquid biopsies from plasma enable early disease detection, such as cancer or autoimmune markers.
- Study Reproducibility: Comprehensive clinical metadata ensures reliable, reproducible results.
- Diverse Populations: Samples from varied genetic and environmental profiles support inclusive research.
- Ethical Standards: Compliance with regulations builds trust and ensures research integrity.
MT Group’s human biospecimen collection services address these needs, delivering customized solutions for researchers worldwide.
About MT Group
Founded in 2003 by Dr. Tom Moss and Marc Siegel, MT Group is a Los Angeles-based boutique CRO specializing in human biospecimen collection. With over 20 years of experience, MT Group serves pharmaceutical, biotechnology, and diagnostic industries, focusing on oncology, autoimmune diseases, and robust control populations.
MT Group pioneered comprehensive clinical annotation in 2003, providing metadata like medical histories, treatment responses, and disease progression. Their network of 150+ procurement sites across the U.S., South America, Europe, and Asia ensures diverse, ethically sourced samples, with strong U.S. locations enabling overnight fresh delivery. Led by experts like John Kibler (VP of Business Development), MT Group combines medical and operational expertise to deliver tailored solutions.
MT Group’s Biospecimen Collection Services
MT Group offers a suite of services to facilitate human biospecimen collection, designed to meet the rigorous demands of translational research:
| Service | Description |
|---|---|
| Custom Collections | Tailored programs for fresh, frozen, or FFPE tissues, blood, urine, and synovial products, including longitudinal studies for specific clinical scenarios. |
| Clinical Metadata | Comprehensive annotations, including medical histories, standard-of-care reports, and treatment outcomes, since 2003. |
| Quality Assurance | Board-certified pathologist review and no-charge replacement for substandard samples. |
| Global Sourcing | 150+ sites for diverse populations, with overnight fresh delivery in the U.S. |
| Specialized Programs | Autoimmune and oncology biobanks, including SCLC FFPE samples and matched FFPE-plasma-buffy coat cases. |
These services ensure researchers have access to high-quality, ethically sourced human biospecimens tailored to their specific study needs.
Case Studies: Real-World Impact
Oncology CTC Research Success
In 2024, MT Group supported a biotech client with a longitudinal blood collection program for circulating tumor cells (CTCs) in prostate cancer. By refining pre-analytic parameters (e.g., PSA values, metastasis status), MT Group achieved a 60%+ positivity hit rate, fostering a long-term partnership. This case underscores their expertise in human biospecimen collection and study design.
Autoimmune Disease Breakthrough
MT Group’s autoimmune disease program provided FFPE samples from 50+ centers for a 2024 rheumatoid arthritis study. Their comprehensive metadata enabled precise analysis of treatment responses, achieving a 98% sample quality rate, demonstrating their leadership in human biospecimen collection.
Researcher Testimonials
“MT Group’s responsiveness, flexibility, and high-quality samples were essential to our oncology study’s success.” – Dr. Jane Smith, Biotech Researcher
“We are deeply grateful to MT Group for their impeccable service and rare, high-quality samples that transformed our research.” – California Biotech CEO
Frequently Asked Questions
What is human biospecimen collection?
Human biospecimen collection involves acquiring biological samples like tissue, blood, and biofluids for research, paired with clinical metadata to ensure precision.
How does MT Group ensure biospecimen quality?
MT Group uses board-certified pathologist review and replaces substandard samples at no cost, ensuring high-quality biospecimens.
What types of biospecimens does MT Group collect?
MT Group collects fresh, frozen, and FFPE tissues, blood products, urine, and synovial products, tailored for oncology, autoimmune, and control populations.
Conclusion
Human biospecimen collection is critical for advancing translational research, and MT Group excels in delivering high-quality, ethically sourced samples with comprehensive clinical metadata. Their 20-year legacy, global network, and customized solutions make them a trusted partner for oncology, autoimmune, and infectious disease research. Explore their services or contact them to elevate your research in 2025.
Written by the MT Group Team. Share this article on LinkedIn or email it to a colleague.
Our Comprehensive Biospecimen Services
Global Biospecimen Acquisition
Secure human biospecimens from our extensive network of clinics and biobanks worldwide.
Efficient Collection & Logistics
Optimize your research with our expert logistics management, including cold chain solutions.
Concierge Sourcing & CRO Support
Access rare and specific sample types with our personalized concierge services and CRO partnerships.
Explore Our Comprehensive Services
Your Trusted Partner in Human Biospecimen Acquisition
At Human Biospecimen Acquisition, we pride ourselves on delivering unparalleled biospecimen collection and logistics management. Our services are tailored to meet the unique requirements of biotech companies, pharmaceutical firms, and research organizations worldwide.
Our commitment to quality and compliance ensures that all specimens are ethically sourced and handled with the utmost care. We offer a wide range of biospecimen formats, including FFPE, fresh frozen, and whole blood, to support diverse research needs.